Takeda купит препарат Nimbus от псориаза за 6 млрд долларов

@Farmatsevticheskij vestnik
#Finances & Markets#Large business
Таким образом компания хочет расширить портфель препаратов на фоне потери...
Copyright information of photo and video materials was taken from the website «Pharmaceutical messenger» , more details in our Terms of Service
Analysis
×
Quotes
All Quotes
Addition of this TYK2 inhibitor to our portfolio of preparations at a late stage provides to Takeda the fascinating program which can expand considerably our portfolio, and also strengthen our strategy of growth beyond limits "Entivioo
Christophe Veber12/14/2022
People
Person ranking
Christophe Veber
Last position: President, chief executive officer (Takeda Pharmaceutical Co., Ltd)
Organizations
Organization Ranking
72
72